Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

NCT06319170 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

NCT06315283 ·Status: COMPLETED ·Phase: PHASE1

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

NCT00239109 ·Status: COMPLETED ·Phase: PHASE4

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

NCT00034801 ·Status: COMPLETED ·Phase: PHASE4

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

NCT00145444 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

NCT00094640 ·Status: COMPLETED ·Phase: PHASE1

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

NCT00647777 ·Status: COMPLETED ·Phase: PHASE1

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00103571 ·Status: COMPLETED ·Phase: PHASE4

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

NCT00485498 ·Status: COMPLETED ·Phase: PHASE4

A Study of Olanzapine in Patients With Schizophrenia

NCT00970281 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

NCT00485901 ·Status: COMPLETED ·Phase: PHASE3

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

NCT00910988 ·Status: COMPLETED ·Phase: NA

Zyprexa and Task Engagement in Schizophrenia

NCT00440843 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

NCT00156117 ·Status: COMPLETED ·Phase: PHASE3

Treating Drug-Resistant Childhood Schizophrenia

NCT00048828 ·Status: COMPLETED ·Phase: PHASE4

Effects of Antipsychotic Medications on Energy Intake and Expenditure

NCT00836251 ·Status: COMPLETED

Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

NCT00797277 ·Status: COMPLETED ·Phase: PHASE3

Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia

NCT02918825 ·Status: COMPLETED ·Phase: NA

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

NCT02307396 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

NCT00210769 ·Status: COMPLETED ·Phase: PHASE3

Study of Blood Lactate Levels in Patients Treated With Antipsychotics

NCT01139463 ·Status: COMPLETED

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

NCT00100776 ·Status: COMPLETED ·Phase: PHASE4

Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

NCT05123976 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

NCT00510211 ·Status: COMPLETED

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

NCT00734435 ·Status: TERMINATED ·Phase: PHASE2